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Background: Delirium is the most frequent complication among older people following hospitalisation. Delirium
may be prevented in about one-third of patients using a multicomponent intervention. However, in the United
Kingdom, the National Health Service has no routine delirium prevention care systems. We have developed the
Prevention of Delirium Programme, a multicomponent delirium prevention intervention and implementation
process. We have successfully carried out a pilot study to test the feasibility and acceptability of implementation of
the programme. We are now undertaking preliminary testing of the programme.
Methods/Design: The Prevention of Delirium Study is a multicentre, cluster randomised feasibility study designed
to explore the potential effectiveness and cost-effectiveness of the Prevention of Delirium Programme. Sixteen
elderly care medicine and orthopaedic/trauma wards in eight National Health Service acute hospitals will be
randomised to receive the Prevention of Delirium Programme or usual care. Patients will be eligible for the trial if
they have been admitted to a participating ward and are aged 65 years or over. The primary objectives of the
study are to provide a preliminary estimate of the effectiveness of the Prevention of Delirium Programme as
measured by the incidence of new onset delirium, assess the variability of the incidence of new-onset delirium,
estimate the intracluster correlation coefficient and likely cluster size, assess barriers to the delivery of the
Prevention of Delirium Programme system of care, assess compliance with the Prevention of Delirium Programme
system of care, estimate recruitment and follow-up rates, assess the degree of contamination due to between-ward
staff movements, and investigate differences in financial costs and benefits between the Prevention of Delirium
Programme system of care and standard practice. Secondary objectives are to investigate differences in the
number, severity and length of delirium episodes (including persistent delirium); length of stay in hospital; in-
hospital mortality; destination at discharge; health-related quality of life and health resource use; physical and social
independence; anxiety and depression; and patient experience.
Discussion: This feasibility study will be used to gather data to inform the design of a future definitive randomised
controlled trial.
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Delirium (also called acute confusion or toxic confu-
sion) is a common condition affecting older people, es-
pecially those who have dementia. In the United
Kingdom, national policy has identified the improved
management of delirium as a priority [1], and national
guidelines are available [2, 3]. Yet, there is much evi-
dence that delirium represents a largely unrecognised
condition affecting older people within health care ser-
vices internationally [4]. It is also now recognised that
health care systems and services frequently have attri-
butes that unintentionally stimulate or aggravate delir-
ium in older people [4]. Demographic transitions of
populations have required health services internation-
ally to address the needs of older people as a priority.
The National Health Service (NHS) in the United
Kingdom has been slow to recognise that the modern
general hospital is increasingly an older person’s facil-
ity, with over two-thirds of the beds occupied by
people older than 65 years of age, many of whom have
complex needs requiring multidisciplinary care [5].
General hospitals, however, have poorly developed care
systems that are not yet fully aligned to the needs of
this vulnerable group [6].
Delirium is the most frequent complication of hospi-
talisation for older people [7], with an occurrence in
general medical and old age medicine wards of 29–64 %
[8]. The large majority of delirium episodes remain un-
detected or misdiagnosed by ward teams [3]. Delirium
is an unpleasant experience for patients [9]. The ex-
perience of delusions and hallucinations during delir-
ium may be associated with the development of later
neuropsychiatric symptoms [10]. The development of
delirium is associated with increased mortality rates,
functional decline, falls and increased requirement for
institutional care [8]. Symptoms of delirium can persist
in some patients for up to 12 months [11], and in-
hospital delirium has also been linked with depression
after hospital discharge [10].
Persistent delirium refers to the situation in which the
delirium symptoms do not resolve [12]. Dementia is the
strongest risk factor for persistent delirium [13–16], but
age and comorbidity are additional factors [17]. The au-
thors of a systematic review of 18 studies involving 1322
hospital patients older than 50 years of age (mean age,
72–89 years; median age, 82 years) with prevalent or in-
cident delirium reported the rates of persistent delirium
as 45 %, 33 %, 26 % and 21 % at hospital discharge and
1, 3 and 6 months postdischarge, respectively [12]. Per-
sistent delirium is directly linked to poor outcomes:
Each 48 hours spent with delirium is associated with an
11 % increase in mortality [18].
Perhaps the most important aspect of delirium is that
multicomponent non-pharmacological interventions cansignificantly reduce delirium incidence (odds ratio, 0.47;
95 % confidence interval, 0.38–0.58) [19]. Intervention
delivery strategies have included additional staff and
volunteers [20–22], proactive geriatric consultation [23],
training family members [24] and sustained education
[25, 26]. Not all studies have found a reduction in delir-
ium incidence [27], and a high degree of protocol ad-
herence is a critical issue for success [28]. Researchers
have primarily examined outcomes in a research con-
text and, with few exceptions, have not addressed how
to achieve sustainability in routine care [29]. The main
exception has been the Hospital Elder Life Program
(HELP), which has been widely sustained in routine
care outside the United Kingdom [30–32].
However, the existing delirium evidence base is suffi-
ciently robust to present a clear opportunity for the
NHS to address the necessary professional skills, cultural
aspects and service design in such a way as to prevent
or attenuate delirium in older people [11]. There are
strong arguments based on international research to
suggest that delirium prevention and its improved man-
agement should be fundamentally predicated within
high-quality care processes for older people [33–37],
particularly care processes that recognise the specific
needs of older people with cognitive impairment. Clinical
teams need validated support systems to help them
achieve this [38]. Importantly, there is evidence to indicate
that multicomponent interventions can improve outcomes
[11, 19]. Unfortunately, the NHS does not have routine
care systems capable of minimising the impact of this
common condition. Consequently, many older patients
are currently disadvantaged in terms of outcomes, and
considerable additional acute bed days are unnecessarily
used [6].
A multicomponent intervention to prevent delirium
was developed as part of a programme of interlinked
studies with the aim of improving delirium prevention
for older people in hospital and reduce the burden of
delirium for the NHS. The development work followed
the Medical Research Council framework for complex
interventions [39]. First, we convened a development
team (consisting of a senior manager, clinicians, ma-
tron, nurse consultant, specialist nurse, staff nurse,
therapist, manager of the volunteer service, patient rep-
resentative, care assistant and ward clerk) to review an
evidence-based, multicomponent delirium prevention
system of care (HELP) previously developed in the
United States [20, 21]. This was augmented by up-to-
date evidence for delirium prevention from the Na-
tional Institute for Health and Care Excellence (NICE)
[3]. In this review process, we identified candidate
implementation and delivery strategies to produce the
Prevention of Delirium Programme (POD) system of care.
Second, we performed an implementation pilot in five
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ceptability of the POD system of care. Key findings
emerged about implementation and delivery, and some
modifications of the content and presentation of the POD
manuals and associated toolkit were made before imple-
mentation in the feasibility study [40]. Here we report the
protocol for a third study designed to explore preliminary
estimates of effectiveness and cost-effectiveness of the
modified version of the POD system of care in older
patients at risk of developing delirium. The data ob-
tained from this feasibility study will be used to inform
the design of a possible future definitive randomised
controlled trial (RCT).
Methods/Design
Aims and objectives
We aim to conduct a pragmatic, multicentre, cluster
randomised, controlled feasibility study to explore the
potential effectiveness and cost-effectiveness of the
POD system of care versus standard care practice in
older patients at risk of developing delirium who are
admitted to hospital for emergency care. The study
objectives relate to gathering data to inform the feasi-
bility of conducting a definitive RCT. The primary ob-
jectives are to
1. Provide a preliminary estimate of the effectiveness of
POD compared with standard care as measured by
the incidence of new-onset delirium within 10 days
of hospital admission (anticipated primary outcome
for a definitive trial)
2. Assess the variability of the incidence of new-onset
delirium within 10 days of hospital admission in
both treatment groups
3. Estimate the intracluster correlation coefficient and
likely cluster size
4. Assess barriers to the delivery of the POD system of
care
5. Assess compliance with the POD system of care
6. Estimate recruitment and follow-up rates at both
patient and cluster levels
7. Assess the degree of contamination at ward level
due to between-ward staff movements
8. Investigate differences in financial costs and benefits
between the POD system of care and standard
practice
Our secondary objectives are to investigate differences
in the number, severity and length of delirium episodes
(including persistent delirium); length of stay in hospital;
in-hospital mortality; destination at discharge; health-
related quality of life and health resource use; physical
and social independence; anxiety and depression; and
patient experience.Setting
Ward inclusion criteria
The study will be conducted in eight NHS hospitals
(16 wards) which care for those at risk of developing
delirium (geriatric medicine or orthopaedic trauma
wards). The following ward criteria were identified in
the preliminary study and were applied to maximise
the likelihood of successful implementation of the
POD system of care:
1. Involvement of senior nurse, ward manager and
voluntary services manager (if voluntary services
were selected by local staff as a component of the
intervention)
2. Named person responsible for supporting the
implementation of POD (e.g., a senior nurse)
3. Dedicated time (equivalent to 1 day per week)
of an experienced senior nurse to lead the
implementation period (funded with the
research grant)
4. Adequate staffing levels as assessed in reference to
guidance on nurse staffing [41, 42]
Ward exclusion criteria
Wards that previously participated in research leading to
the development of the POD system of care, as well as
wards that intend to implement a delirium prevention
initiative during the duration of the study, will not be
eligible, because these sites might have enhanced skills
or knowledge about delirium prevention.
Patient inclusion criteria
Patients aged 65 years and older who are admitted to a
participating ward will be eligible for study participation.
Patient exclusion criteria
Patients meeting any of the following criteria will not be
eligible for study entry:
 Patients with prevalent delirium (diagnosed by using
the confusion assessment method (CAM) [43]
 Patients with a discharge from hospital planned
within 48 hours of admission
 Patients for whom a delirium assessment (via the
CAM) has not been performed within 24 hours of
admission to the ward (for elderly care patients) or
for whom a delirium assessment has not been
performed preoperatively (e.g., patients with hip
fracture)
 Patients who have not provided consent or, for
patients who lack the capacity to provide consent,
where there is no agreement from a consultee for
trial participation within 48 hours of the patient’s
admission to the ward
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likely follow-up data will be collected from these
patients)
 Patients from another ward who are not under the
care of the ward medical team
Unit of randomisation
Cluster randomisation has been chosen to reduce
between-group contamination, as the POD system of care
is a ward-based intervention which aims to affect staff
skills, knowledge and clinical practice. As patients on a
ward receive the allocated treatment, it is not possible to
use the patient as the unit of randomisation. It is not
known whether treatment contamination might occur be-
tween wards owing to staff movement, and therefore this
will be investigated by randomising half of the hospitals at
the hospital level (control or intervention) and half of the
hospitals at the ward level. Randomisation will stratify by
ward type (geriatric medicine and orthopaedic trauma)
and is a two-stage process which will be performed cen-
trally by the statistician at the Clinical Trials Research Unit
(CTRU). Sites will first be randomised 1:1 between site-
(i.e., hospital)-level allocation (both wards in the hospital
receive the same intervention) and ward-level allocation
(each ward in the hospital receives a different interven-
tion). Those sites selected for site-level allocation will then
be further randomised 1:1 for both of their wards to re-
ceive either POD or control. Wards in those sites selectedFig. 1 Randomisaion overviewfor ward-level allocation will be randomised 1:1 to receive
either POD or control (Fig. 1).
Training in study procedures
Research assistants (RAs) will be appointed at each
hospital to recruit study participants and perform study
procedures.
Training in the use of the CAM [43] to detect delirium
will be provided by the central trial team in consultation
with the instrument developer. The diagnostic version of
the CAM has four items: (1) acute onset and fluctuating
course, (2) inattention, (3) disorganised thinking and
(4) altered consciousness level. A diagnosis of delirium
requires positive results for items (1) and (2) and ei-
ther (3) or (4). Administration of the CAM takes 3–5
minutes and is informed by a formal cognitive assess-
ment. In validation studies, researchers have reported
a sensitivity range of 94–100 % and a specificity range
of 90–95 % [44].
The RAs, before recruitment, will follow the recom-
mended training procedure [45] by co-assessing up to 10
patients with or without delirium to ensure acceptable
inter-rater reliability (IRR). This prerecruitment training
method will also provide an important opportunity for
the RAs to work alongside the ward staff and become
more integrated and familiar with ward routines and
practices. The RAs will use a standard procedure to
undertake the CAM [45]. First, where possible, relevant
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from patients’ relatives and/or carers. Then, following an
informal general conversation with the patient, formal
cognitive testing will be undertaken using the Abbrevi-
ated Mental Test Score [46] and the calendar months
backwards test [47]. Finally, the CAM questions will be
scored (Table 1). Ongoing sessions to discuss coding
questions will enhance reliability.
The RAs will undertake further IRR assessments ap-
proximately halfway through the data collection period.
Intervention
POD is a manualised, multicomponent intervention and
systematic implementation process designed to secure
ward practice changes, potentially enhanced by the in-
volvement of hospital volunteers. It builds on current
best evidence on delirium prevention [3], conceptually
driven empirical research [48] and reviews of implemen-
tation [29, 49, 50].
The POD intervention comprises actions centred on
10 targeted risk factors associated with the development
of delirium among those who are vulnerable on of the
basis of predisposing risk [3]. These interventions dir-
ectly affect the patient experience of care and include
optimising hydration and nutrition, reducing environ-
mental threats (excessive noise, multiple moves), in-
creasing orientation to time and place, improving
communicative practices (personally meaningful inter-
action and cognitive stimulation), supporting and/or en-
couraging mobility and better management of pain and
infection. The implementation process is supported and
reinforced through raising awareness and training of
staff and volunteers in delirium prevention. Alongside
this, staff will be involved in an action-planning cycle of
observation and audit of current practice to establish
what needs to be put in place to introduce the POD sys-
tem of care. The principles underpinning POD and the
steps in the change process to facilitate action on the
intervention are standard and generalisable, although theTable 1 Confusion assessment method questions and source of info
Question Source of information
1. Acute onset and fluctuating course Ward staff or relative/carer who know
time
Medical/nursing notes, including the
2. Inattention Informal general conversation
Formal cognitive testing: Abbreviated
3. Disorganised thinking Informal general conversation
Formal cognitive testing: Abbreviated
4. Altered level of consciousness Ward staff
Informal general conversation
Observation
Confusion Assessment Method. © 1988, 2003, Hospital Elder Life Program. Used witspecific systems or mechanisms are flexible, depending
on preexisting practice and local decision-making.
Wards randomised to the POD system of care will
undergo a 6-month implementation period to allow the
intervention to be embedded into ward practice before pa-
tient recruitment. Local implementation teams, including a
study-specific ward nurse, will be convened, and training
will be provided in the implementation and delivery of the
POD system of care by the central trial team. Progress on
implementation will be monitored by the central trial team
through regular site visits and telephone and/or email con-
tact and will be tracked through completion of an internal
milestone checklist embedded within the POD manual.
Usual-care control group
Wards randomised to the usual-care control group will
continue to deliver care as determined by local policies
and practices.
Recruitment and consent
Following a 6-month implementation period for the POD
intervention, study participants will be recruited over a 6-
month period. All patients 65 years of age or older admitted
to a participating ward will be considered for enrolment
into the study in a three-stage recruitment process:
1. Initial screening for eligibility will be established
through a liaison between the RA and the ward
staff (stage 1).
2. Patients will be screened for the presence of
delirium by the RA within 24 hours of admission to
the ward (e.g., elderly care patients) or
preoperatively (e.g., hip fracture patients) (stage 2).
3. Patients who do not have prevalent delirium will
then be invited by the RA to participate in the trial
within 48 hours of admission to the ward. The RA
will obtain informed consent from the participant or,
if the patient lacks the capacity to provide consent,
from a personal or nominated consultee (stage 3).rmation
s the patient’s baseline mental status and has observed the patient over
baseline Abbreviated Mental Test Score
Mental Test Score [46], months of the year backwards test [47]
Mental Test Score [46], months of the year backwards test [47]
h permission
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process.
Recruitment of patients at risk of reduced capacity
Capacity is likely to be a major issue in this study popu-
lation, as the presence of dementia may reduce patients’
capacity to give consent.
The Mental Capacity Act 2005 (MCA; http://www.legi-
slation.gov.uk/ukpga/2005/9/contents) requires that those
lacking capacity are only included in research that is likely
to be of direct benefit to those taking part or to benefit theFig. 2 Recruitment overviewparticular population under study. In this study, ward pa-
tients receiving the POD intervention may benefit directly
from improved quality of care. Another potential direct
benefit for those taking part in the study is that screening
assessments for delirium on admission to the ward may
identify people with delirium at an earlier stage, allowing
earlier treatment.
Excluding those without capacity from this research
would not be ethical, as it would compromise the
generalisability of findings by recruitment of an unrepre-
sentative study sample and would exclude this vulnerable
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practice.
To comply with the MCA, ethical approval was ob-
tained to seek personal consultee or nominated con-
sultee agreement for patients with impaired capacity and
for participants who lost capacity following the provision
of informed consent.
Data collection
The screening data will be obtained by the RA in con-
sultation with the attending ward staff and will include
demographic characteristics, admission details and,
where applicable, assessment of capacity and a delir-
ium screen and/or CAM severity rating (CAM-S) [43,
45] for all patients older than 65 years of age admitted
to the ward. Baseline assessment will be conducted by
the RA and will include admission details, reason for
admission, medical history (including the Charlson co-
morbidity index) [51], existing hearing and or visual
impairments, current medication use, illness severity
(using an early warning score [National Early Warning
Score or equivalent]), CAM-S), cognitive assessment
(history of dementia and Abbreviated Mental Test Score)
[46], medications and living arrangements. Participants will
complete questionnaires relating to physical and social
independence (Nottingham Extended Activities of Daily
Living Scale) [52] and health-related quality of life
(EuroQol [EQ-5D]) [53]. The RA will perform daily cogni-
tive and CAM assessments for up to 10 days postadmis-
sion (or until discharge, whichever is sooner) to detect the
incidence of new delirium.
At 30 days after admission to the ward, the RA will
perform a cognitive assessment and CAM and ask the
patient to complete questionnaires about health-related
quality of life (EQ-5D) [53], anxiety and depression
(using the Clinical Anxiety Scale [54] and the Geriatric
Depression Scale Short Form [55], respectively) and
about patient experience using selected questions in the
patient-reported experience measure from the National
Audit of Intermediate Care [56]. At the point of dis-
charge, the RAs will collect data on the date of discharge
(or date of death), causes of death (if known), falls oc-
curring (and reason for fall if known) between the date
of consent and date of discharge using local recording
procedures (e.g., falls incidence records) and discharge
destination.
At 3 months after admission to the ward, postal ques-
tionnaires will be used to provide information on physical
and social independence (Nottingham Extended Activities
of Daily Living Scale) [52], health-related quality of life
(EQ-5D) [53], health care resource use (post discharge
contact with health and social care services) and informa-
tion on living arrangements. Proxy completion of the
questionnaires and the resource use will be permitted.A summary of the assessments to be used is given in
Table 2.
Compliance with the POD system of care will be
assessed by the central trial team through review of
site-specific POD documentation, case note review and
researcher-conducted observations of ward care using
the method employed in the 2013 National Audit of
Dementia Care in General Hospitals [57]. Sustainabil-
ity will be assessed through observations of ward care
approximately 3–6 months post recruitment through
central trial team researcher-conducted observations
of ward care. Information will be collected on inter-
vention delivery, recruitment uptake, follow-up rates,
missing data, length of hospital stay, staff movement
(to allow for an assessment of potential contamination),
the number of falls between consent and discharge, and
deaths occurring up to 3 months post admission. We will
also collect related and unexpected serious adverse events.
Sample size
We aim to recruit 720 patients into this feasibility study.
This is based on the following assumptions:
 Average length of stay of 14 days and 25-bed wards
will provide a recruitment pool of 4800 patients over
the course of 6 months.
 Fifty percent of patients are assumed to be at risk of
delirium, giving 2400 eligible patients.
 On the basis of previous studies of comparable
populations [58, 59], 30 % of patients will consent.
Because this is a feasibility study, a formal power calcula-
tion is not appropriate, as effectiveness is not being evalu-
ated. The results generated from this study will be used to
inform the power calculation for a possible definitive study.
Analysis
Statistical analysis is the responsibility of the University of
Leeds CTRU statistician, and a final statistical analysis plan
will be written before any analysis is undertaken. All ana-
lyses and data summaries will be conducted on the
intention-to-treat (ITT) population, defined as all partici-
pants registered, regardless of non-compliance with the
protocol or withdrawal from the study. No formal interim
analyses are planned, and final analysis will take place when
all available data have been received. The analysis will be fo-
cused on descriptive statistics and confidence interval esti-
mation rather than on formal hypothesis testing.
Primary analysis
Estimation of effectiveness for a possible definitive
randomised controlled trial To inform the sample size
calculation for a possible definitive trial, we will calculate
Table 2 Summary and timing of assessments
Assessment Screening/
recruitment
Baseline Daily (up to
10 days
from date
of admission)
30 days
(postadmission)
Discharge Follow-up
(3 mo postadmission)
Demographic data (age, sex, ethnicity) X
Admission details (date and time of admission to hospital
and ward)
X
Assessment of capacity X
Delirium screen (confusion assessment method) and
delirium severity rating (CAM-S)
X X X
Date of discharge and discharge destination (living alone,
living with another person, nursing home, residential care
home or other)
X
Reason for admission (hip fracture, other orthopaedic
condition, medical condition) and medical history
(Charlson comorbidity index, existing hearing and/or visual
impairments, current medication use [benzodiazepines,
opiates, H1 antihistamines])
X
Cognitive impairment: (1) history of dementia, (2) low
Abbreviated Mental Test Score on admission
X
Illness severity using National Early Warning Score or
equivalent
X
Living arrangements (living alone, living with another
person, nursing home, residential care home or other)
X X X
Nottingham Extended Activities of Daily Living Scalea X X
EuroQol EQ-5Da X X X
Geriatric Depression Scale Short Forma X
Clinical Anxiety Scale X
Patient-reported experience measure X
Falls (and reason for fall if known) Occurring between the date of consent and date of discharge
Health care resource use (postdischarge contact with
health and social care services)a
X
Abbreviation: CAM-S confusion assessment method severity rating
aProxy completion permitted where appropriate
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admission by ward type, overall and per arm, together
with corresponding 95 % confidence intervals. Estima-
tion of effectiveness will be carried out on the ITT
population using multilevel logistic regression adjusting
for NICE risk factors for delirium, medications which
could impact on the development of delirium, hearing
impairment and use of hearing aid, visual impairment
and ward type. Ward type will be fitted as a random ef-
fect in the model. Odds ratios, 95 % confidence intervals
and p values will be reported. The number of new pa-
tients admitted per ward during the recruitment period
will be used to estimate cluster size. The intracluster
correlation coefficient will be calculated using the inci-
dence of new-onset delirium expressed as a proportion.
Assessment of intervention delivery and compliance
The progress of wards randomised to POD will be
assessed by completion of the internal milestone checklist,which includes the length of time taken to complete each
core task (staff education, review of current practice and
ward systems) and overall time spent implementing POD,
the number of sites and/or wards failing to progress
through implementation milestones and reasons for
failure, the number of sites and/or wards withdrawing
during the implementation and delivery phases, the
number of sites withdrawing from the study, timing
and reason for withdrawal, case notes review and re-
view of ward observation of care.
Estimation of recruitment uptake To assess the feasi-
bility of recruiting participants, the numbers of patients
who are screened, are eligible, are assessed for delirium,
have prevalent delirium, have capacity to consent, con-
sent to trial registration and are registered will be sum-
marised. Loss to follow-up at 30 days and 3 months, as
well as the number, timing and reasons for withdrawals,
will also be reported.
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ber of staff moving between study wards within sites will
be reported. The incidence rates of new-onset delirium
at the sites that were randomised at the hospital level
will be calculated and compared with those from sites
that were randomised at the ward level to assess the de-
gree of contamination between wards.
Secondary outcomes
The following secondary outcomes will reported: (1) the
number and length of delirium episodes during hospital
stay and the number of days between admission to ward
and the occurrence of delirium and (2) the outcome of
the patient-reported questionnaires.
The number of deaths, the number of eligibility violations
and the number of participants who fall during their hos-
pital stays will also be reported overall and by arm. The type
of living accommodation at 3 months will be compared
with that at baseline and intended discharge location.
Cost-effectiveness
The primary analysis will take the perspective of the ser-
vice provider, including the costs of health and personal
social services. Discounting will not be applied, given the
duration of the trial. Multilevel modelling and regression
analysis (dependent variable: net benefit) will be the focus,
which will allow us to control for baseline covariates and
subgroup analysis [60]. Sensitivity analyses will be con-
ducted to explore the impacts on the study results of using
proxy versus patient reports, of using different methods to
handle missing data and of using different volunteer time
valuation techniques. In the secondary analysis, we will
adopt a societal perspective, taking account of productivity
costs and out-of-pocket expenditures incurred by patients,
carers and volunteers.
Criteria for continuation to the definitive randomised
controlled trial
Guidelines for progression to a definitive RCT have been
defined as a minimum of six wards (75 %) completing the
milestone checklist (to provide assurance that the POD
implementation was successful and the overall recruit-
ment rate of at least 10 % of the total recruitment pool).
Data monitoring
Trial supervision includes a core project team, a trial
management group and a trial steering committee. For a
feasibility study of this nature and duration, a separate
data monitoring and ethics committee is not required;
rather, the trial steering committee adopts a safety moni-
toring role, with the constitution of a subcommittee to
review safety issues if this becomes necessary.
Data will be monitored for quality and completeness
by the CTRU. Missing data (except individual itemscollected via postal questionnaires) will be chased until
received, confirmed as not available or the trial is at
analysis.
Trial organisation and administration
The POD study is funded by the National Institute for
Health Research under its Programme Grants for Applied
Research Programme (grant RP-PG-0108-10037). The trial
is sponsored by the Bradford Teaching Hospitals NHS
Foundation Trust and is co-ordinated by the Academic
Unit of Elderly Care and Rehabilitation (Bradford Teaching
Hospitals NHS Foundation Trust and University of Leeds)
and the CTRU (Leeds Institute of Clinical Trials Research,
University of Leeds). The trial management group consists
of the co-applicants and the teams from the co-ordinating
units.
The study is adopted by the U.K. Clinical Research Net-
work (CRN) and is supported in part by the CRN trained
research staff. The trial is registered (ISRCTN01187372).
The trial will be conducted in accordance with the princi-
ples of Good Clinical Practice, the NHS Research Govern-
ance Framework and through adherence to CTRU
standard operating procedures. Ethical approval has been
obtained through the U.K. National Research Ethics Service
(13/YH/0400). The results of the study will be published in
peer-reviewed publications and will be presented at relevant
national and international conferences. We will work with
the public and patient involvement representatives to de-
velop lay reports to disseminate research findings to patient
groups and the clinical teams at participating sites.
Discussion
Delirium is a common condition and is the most fre-
quent complication of hospitalisation in older people. It
is strongly associated with adverse outcomes, and the
burden to the patient, family, carer and the health care
system is considerable. Evidence suggests that delirium
can be prevented in more than one-third of patients
through modifications to selected risk factors which can
be incorporated and delivered within high-quality care
processes for elderly patients. NICE demonstrated that
such care systems are likely to be cost-effective [61] and
recommended they should be widely deployed in routine
care [62]. Our work comprises a sequence of linked
studies to develop and evaluate a multicomponent inter-
vention to prevent delirium. The protocol for the ongoing
feasibility randomised trial described here has presented
some critical implementation challenges, which are de-
scribed below.
Implementation of the POD system of care
A key aspect of this study is to implement and sustain a
multicomponent system of care across different wards
and hospitals. Earlier studies within this programme
Young et al. Trials  (2015) 16:340 Page 10 of 12sought to identify the feasibility and acceptability of the
POD system of care and to refine its content before
commencing this feasibility study. This also provided in-
sights into the conditions required to inform the site se-
lection processes.Recruitment and retention
This is a cluster randomised controlled trial, and all
participants admitted to a participating ward will re-
ceive the POD system of care or usual care. Consent
for participation is therefore for the provision of data
only. Nonetheless, we anticipate challenges in the iden-
tification, recruitment and retention of study partici-
pants in a population at risk of fluctuating capacity. We
aim to minimise the risk of this through involvement of
patient groups in the development of the participant in-
formation and recruitment processes and the provision
of ongoing training and support to the RAs, obtaining
ethical approval to obtain personal or nominated con-
sultee agreement and implementing strategies to maximise
data completion (e.g., allowing proxy completion and
telephone reminders).Reliable assessment of delirium
CAM is widely used in the clinical research setting to re-
liably detect delirium and can be used by clinicians with-
out psychiatric training. We propose to implement a
prerecruitment training programme to ensure that the
RAs are competent and reliable in conducting the CAM
assessment, using validated procedures provided by the
instrument developer, who is a member of the study
team. We will also provide appropriate training manuals
and further assess the IRR during the proposed research.
The findings from the POD study will inform the design
and development of a future definitive trial, which could
change the way in which care is provided to elderly pa-
tients in U.K. hospitals.Trial status
Recruitment completed on 28 February 2015 and the last
3 month follow-up took place on 19 June 2015. Analysis is
underway and the trial results will be available in late
2015.
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